Nighttime recordings of brain signals while changing deep brain stimulation in Parkinson's disease
Official title: Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease - The DREAMS-PD Study
Run by The Cleveland Clinic · NCT07110376 · Data updated 2026-11-12
This project tests whether changing nighttime deep brain stimulation settings and recording brain signals during sleep can help understand and improve sleep in people with Parkinson's disease who have a Medtronic Percept PC implant.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | November 22, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT07110376 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with idiopathic Parkinson's disease who have bilateral Medtronic Percept PC STN implants with stable, optimized settings for at least three months, can ambulate independently, and can provide informed consent.
✕Probably not a fit
Patients without the Percept PC device, those with other neurological diseases, untreated significant sleep apnea or active sleep disorders, major cognitive impairment, or who cannot travel to the study site are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This exploratory, prospective, single-center, naturalistic study uses a randomized crossover design to compare different nighttime DBS amplitude settings in people with Parkinson's disease who have bilateral Medtronic Percept PC STN implants. Participants undergo overnight recording of local field potentials (LFPs) and sleep measures while clinicians alternate stimulation amplitudes to capture electrophysiological signatures such as beta-band activity. The goal is to link changes in subcortical beta oscillations with sleep architecture and symptoms to identify biomarkers of the sleep state. Results will inform optimal stimulation parameters for sleep and the potential of LFP-guided adaptive (closed-loop) DBS.
Why it matters
Potential benefit: If successful, this work could identify stimulation settings or neural biomarkers that lead to better nighttime DBS strategies and improved sleep quality for people with Parkinson's.
How similar studies have gone: Prior DBS studies have demonstrated improvements in sleep and motor function, but applying LFP-guided or adaptive DBS specifically during sleep is a relatively novel approach that has not been tested in large trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female \> 18 years of age * Diagnosed with idiopathic Parkinson Disease * Have bilateral implantation of Medtronic's PerceptTM PC (Medtronic Neurological Division, Minneapolis, MN, USA) Deep Brain Stimulation (DBS) system targeting the subthalamic nucleus (STN) and have had their stimulation settings optimized for a minimum of three months * Report a response score of one or greater on question 1.7 of the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part I; * Demonstrate ability to ambulate independently; * Be capable of providing informed consent; * If taking sleep-supporting medications, dosing must be stable for at least 30 days Exclusion Criteria: * Presence of neurological diseases other than Parkinson Disease, such as stroke or multiple sclerosis * Active sleep disorders, including narcolepsy, moderate to severe (Apnea-Hypopnea Index\>=15) untreated sleep apnea, uncontrolled restless legs syndrome * Cognitive impairment meeting the criteria for dementia as per the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), based on formal neuropsychological evaluation * Ongoing alcohol or substance abuse; Working night shifts or irregular work hours The main concern for vulnerable subjects will be for the possibility of reduced decision-making capacity. For this we intend to exclude individuals who have a diagnosis of dementia.
Where it's running
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Study coordinator: Saar Anis, MD
- Email: ANISS2@ccf.org
- Phone: 216 678-8896
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.